Inflammation in joint injury and post-traumatic osteoarthritis

Osteoarthritis and Cartilage

Volumn 23, Issue 11, 2015, Pages 1825-1834

  Lieberthal, J ^a   Sambamurthy, N ^a   Scanzello, C R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chemokines; Cytokines; Inflammation; Joint injury; Osteoarthritis; Post traumatic arthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PLACEBO; AUTACOID;

ARTHRITIS; BONE EROSION; CARTILAGE DEGENERATION; CELL INFILTRATION; CHRONIC DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; INFLAMMATORY CELL; JOINT INJURY; JOINT INJURY INFLAMMATION; MOLECULAR BIOLOGY; NONHUMAN; OSTEOARTHRITIS; PATHOPHYSIOLOGY; POST-TRAUMATIC OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM; TISSUE REACTION; TISSUE REPAIR; ANIMAL; ARTICULAR CARTILAGE; COMPLICATION; INFLAMMATION; INJURIES; INJURY; JOINT; METABOLISM;

ANIMALS; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; JOINTS; OSTEOARTHRITIS; WOUNDS AND INJURIES;

EID: 84945264954     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.08.015     Document Type: Review

References (112)

1. Gelber A.C., Hochberg M.C., Mead L.A., Wang N.Y., Wigley F.M., Klag M.J. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med 2000, 133:321-328.
2. Brown T.D., Johnston R.C., Saltzman C.L., Marsh J.L., Buckwalter J.A. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma 2006, 20:739-744.
3. Felson D.T. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage 2013, 21:10-15.
4. Chalmers P.N., Mall N.A., Moric M., Sherman S.L., Paletta G.P., Cole B.J., et al. Does ACL reconstruction alter natural history?: a systematic literature review of long-term outcomes. J Bone Joint Surg Am 2014, 96:292-300.
5. Dare D., Rodeo S. Mechanisms of post-traumatic osteoarthritis after ACL injury. Curr Rheumatol Rep 2014, 16:448.
6. Englund M., Guermazi A., Lohmander L.S. The meniscus in knee osteoarthritis. Rheum Dis Clin North Am 2009, 35:579-590.
7. Englund M., Guermazi A., Roemer F.W., Aliabadi P., Yang M., Lewis C.E., et al. Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: the Multicenter Osteoarthritis Study. Arthritis Rheum 2009, 60:831-839.
8. Anderson D.D., Marsh J.L., Brown T.D. The pathomechanical etiology of post-traumatic osteoarthritis following intraarticular fractures. Iowa Orthop J 2011, 31:1-20.
9. Sward P., Frobell R., Englund M., Roos H., Struglics A. Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)-a cross-sectional analysis. Osteoarthritis Cartilage 2012, 20:1302-1308.
10. Sward P., Struglics A., Englund M., Roos H.P., Frobell R.B. Soft tissue knee injury with concomitant osteochondral fracture is associated with higher degree of acute joint inflammation. Am J Sports Med 2014, 42:1096-1102.
11. Bigoni M., Sacerdote P., Turati M., Franchi S., Gandolla M., Gaddi D., et al. Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury. J Orthop Res 2013, 31:315-321.
12. Irie K., Uchiyama E., Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 2003, 10:93-96.
13. van Meegeren M.E., Roosendaal G., Jansen N.W., Wenting M.J., van Wesel A.C., van Roon J.A., et al. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage. Osteoarthritis Cartilage 2012, 20:764-772.
14. Helmark I.C., Mikkelsen U.R., Borglum J., Rothe A., Petersen M.C., Andersen O., et al. Exercise increases interleukin-10 levels both intraarticularly and peri-synovially in patients with knee osteoarthritis: a randomized controlled trial. Arthritis Res Ther 2010, 12:R126.
15. Teunis T., Beekhuizen M., Kon M., Creemers L.B., Schuurman A.H., van Minnen L.P. Inflammatory mediators in posttraumatic radiocarpal osteoarthritis. J Hand Surg Am 2013, 38:1735-1740.
16. Cameron M.L., Fu F.H., Paessler H.H., Schneider M., Evans C.H. Synovial fluid cytokine concentrations as possible prognostic indicators in the ACL-deficient knee. Knee Surg Sports Traumatol Arthrosc 1994, 2:38-44.
17. Higuchi H., Shirakura K., Kimura M., Terauchi M., Shinozaki T., Watanabe H., et al. Changes in biochemical parameters after anterior cruciate ligament injury. Int Orthop 2006, 30:43-47.
18. Marks P.H., Donaldson M.L. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee. Arthroscopy 2005, 21:1342-1347.
19. Elsaid K.A., Fleming B.C., Oksendahl H.L., Machan J.T., Fadale P.D., Hulstyn M.J., et al. Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury. Arthritis Rheum 2008, 58:1707-1715.
20. Harkey M.S., Luc B.A., Golightly Y.M., Thomas A.C., Driban J.B., Hackney A.C., et al. Osteoarthritis-related biomarkers following anterior cruciate ligament injury and reconstruction: a systematic review. Osteoarthritis Cartilage 2015, 23:1-12.
21. Anderson D.D., Chubinskaya S., Guilak F., Martin J.A., Oegema T.R., Olson S.A., et al. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res 2011, 29:802-809.
22. Gregory M.H., Capito N., Kuroki K., Stoker A.M., Cook J.L., Sherman S.L. A review of translational animal models for knee osteoarthritis. Arthritis 2012, 2012:764621.
23. Lewis J.S., Hembree W.C., Furman B.D., Tippets L., Cattel D., Huebner J.L., et al. Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthritis Cartilage 2011, 19:864-873.
24. Goetz J.E., Fredericks D., Petersen E., Rudert M.J., Baer T., Swanson E., et al. A clinically realistic large animal model of intra-articular fracture that progresses to post-traumatic osteoarthritis. Osteoarthritis Cartilage 2015, 23:1797-1805. 10.1016/j.joca.2015.05.022.
25. Kamekura S., Hoshi K., Shimoaka T., Chung U., Chikuda H., Yamada T., et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005, 13:632-641.
26. Dymock D.C., Brown M.P., Merritt K.A., Trumble T.N. Concentrations of stromal cell-derived factor-1 in serum, plasma, and synovial fluid of horses with osteochondral injury. Am J Vet Res 2014, 75:722-730.
27. El-Hadi M., Charavaryamath C., Aebischer A., Smith C.W., Shmon C., Singh B. Expression of interleukin-8 and intercellular cell adhesion molecule-1 in the synovial membrane and cranial cruciate ligament of dogs after rupture of the ligament. Can J Vet Res 2012, 76:8-15.
28. Ferrandiz M.L., Terencio M.C., Ruhi R., Verges J., Montell E., Torrent A., et al. Influence of age on osteoarthritis progression after anterior cruciate ligament transection in rats. Exp Gerontol 2014, 55:44-48.
29. Shen P.C., Lu C.S., Shiau A.L., Lee C.H., Jou I.M., Hsieh J.L. Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein-1gamma ameliorates experimentally induced osteoarthritis in mice. Hum Gene Ther 2013, 24:871-882.
30. Smith M.M., Cake M.A., Ghosh P., Schiavinato A., Read R.A., Little C.B. Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Rheumatology (Oxford) 2008, 47:1172-1178.
31. Wei T., Kulkarni N.H., Zeng Q.Q., Helvering L.M., Lin X., Lawrence F., et al. Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage. Osteoarthritis Cartilage 2010, 18:992-1000.
32. Loeser R.F., Olex A.L., McNulty M.A., Carlson C.S., Callahan M.F., Ferguson C.M., et al. Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum 2012, 64:705-717.
33. Loeser R.F., Olex A.L., McNulty M.A., Carlson C.S., Callahan M., Ferguson C., et al. Disease progression and phasic changes in gene expression in a mouse model of osteoarthritis. PLoS One 2013, 8:e54633.
34. Olex A.L., Turkett W.H., Fetrow J.S., Loeser R.F. Integration of gene expression data with network-based analysis to identify signaling and metabolic pathways regulated during the development of osteoarthritis. Gene 2014, 542:38-45.
35. O'Brien E.J., Beveridge J.E., Huebner K.D., Heard B.J., Tapper J.E., Shrive N.G., et al. Osteoarthritis develops in the operated joint of an ovine model following ACL reconstruction with immediate anatomic reattachment of the native ACL. J Orthop Res 2013, 31:35-43.
36. Heard B.J., Solbak N.M., Achari Y., Chung M., Hart D.A., Shrive N.G., et al. Changes of early post-traumatic osteoarthritis in an ovine model of simulated ACL reconstruction are associated with transient acute post-injury synovial inflammation and tissue catabolism. Osteoarthritis Cartilage 2013, 21:1942-1949.
37. Huebner K.D., Shrive N.G., Frank C.B. New surgical model of post-traumatic osteoarthritis: isolated intra-articular bone injury in the rabbit. J Orthop Res 2013, 31:914-920.
38. Huebner K.D., Shrive N.G., Frank C.B. Dexamethasone inhibits inflammation and cartilage damage in a new model of post-traumatic osteoarthritis. J Orthop Res 2014, 32:566-572.
39. Bondeson J., Blom A.B., Wainwright S., Hughes C., Caterson B., van den Berg W.B. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
40. Clockaerts S., Bastiaansen-Jenniskens Y.M., Runhaar J., Van Osch G.J., Van Offel J.F., Verhaar J.A., et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage 2010, 18:876-882.
41. Ushiyama T., Chano T., Inoue K., Matsusue Y. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann Rheum Dis 2003, 62:108-112.
42. Klein-Wieringa I.R., Kloppenburg M., Bastiaansen-Jenniskens Y.M., Yusuf E., Kwekkeboom J.C., El-Bannoudi H., et al. The infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype. Ann Rheum Dis 2011, 70:851-857.
43. McNulty A.L., Miller M.R., O'Connor S.K., Guilak F. The effects of adipokines on cartilage and meniscus catabolism. Connect Tissue Res 2011, 52:523-533.
44. Dhollander A.A., Lambrecht S., Verdonk P.C., Audenaert E.A., Almqvist K.F., Pattyn C., et al. First insights into human acetabular labrum cell metabolism. Osteoarthritis Cartilage 2012, 20:670-677.
45. Haslauer C.M., Elsaid K.A., Fleming B.C., Proffen B.L., Johnson V.M., Murray M.M. Loss of extracellular matrix from articular cartilage is mediated by the synovium and ligament after anterior cruciate ligament injury. Osteoarthritis Cartilage 2013, 21:1950-1957.
46. Attia E., Brown H., Henshaw R., George S., Hannafin J.A. Patterns of gene expression in a rabbit partial anterior cruciate ligament transection model: the potential role of mechanical forces. Am J Sports Med 2010, 38:348-356.
47. Nagai T., Sato M., Kobayashi M., Yokoyama M., Tani Y., Mochida J. Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis. Arthritis Res Ther 2014, 16:427.
48. Tang Z., Yang L., Xue R., Zhang J., Wang Y., Chen P.C., et al. Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in anterior cruciate ligament and medial collateral ligament fibroblasts after a mechanical injury: involvement of the p65 subunit of NF-kappaB. Wound Repair Regen 2009, 17:709-716.
49. Aini H., Ochi H., Iwata M., Okawa A., Koga D., Okazaki M., et al. Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model. PLoS One 2012, 7:e37728.
50. Moradi B., Rosshirt N., Tripel E., Kirsch J., Barie A., Zeifang F., et al. Unicompartmental and bicompartmental knee osteoarthritis show different patterns of mononuclear cell infiltration and cytokine release in the affected joints. Clin Exp Immunol 2015, 180:143-154.
51. Pessler F., Dai L., Diaz-Torne C., Gomez-Vaquero C., Paessler M.E., Zheng D.H., et al. The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann Rheum Dis 2008, 67:1184-1187.
52. Daghestani H.N., Pieper C.F., Kraus V.B. Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol 2015, 67:956-965.
53. Scanzello C.R., McKeon B., Swaim B.H., DiCarlo E., Asomugha E.U., Kanda V., et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011, 63:391-400.
54. Jackson M.T., Moradi B., Zaki S., Smith M.M., McCracken S., Smith S.M., et al. Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms. Arthritis Rheumatol 2014, 66:3337-3348.
55. Mapp P.I., Sagar D.R., Ashraf S., Burston J.J., Suri S., Chapman V., et al. Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis Cartilage 2013, 21:1336-1345.
56. Wu P., Holguin N., Silva M.J., Fu M., Liao W., Sandell L.J. Early response of mouse joint tissue to noninvasive knee injury suggests treatment targets. Arthritis Rheumatol 2014, 66:1256-1265.
57. van Lent P.L., Blom A.B., van der Kraan P., Holthuysen A.E., Vitters E., van Rooijen N., et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 2004, 50:103-111.
58. Blom A.B., van Lent P.L., Libregts S., Holthuysen A.E., van der Kraan P.M., van Rooijen N., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56:147-157.
59. Shen P.C., Wu C.L., Jou I.M., Lee C.H., Juan H.Y., Lee P.J., et al. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1gamma. Osteoarthritis Cartilage 2011, 19:728-736.
60. Hsieh J.L., Shiau A.L., Lee C.H., Yang S.J., Lee B.O., Jou I.M., et al. CD8+ T cell-induced expression of tissue inhibitor of metalloproteinses-1 exacerbated osteoarthritis. Int J Mol Sci 2013, 14:19951-19970.
61. E X., Cao Y., Meng H., Qi Y., Du G., Xu J., et al. Dendritic cells of synovium in experimental model of osteoarthritis of rabbits. Cell Physiol Biochem 2012, 30:23-32.
62. Felson D.T., Anderson J.J., Naimark A., Walker A.M., Meenan R.F. Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med 1988, 109:18-24.
63. Oliveria S.A., Felson D.T., Cirillo P.A., Reed J.I., Walker A.M. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology 1999, 10:161-166.
64. Berenbaum F., Eymard F., Houard X. Osteoarthritis, inflammation and obesity. Curr Opin Rheumatol 2013, 25:114-118.
65. Conde J., Scotece M., López V., Gómez R., Lago F., Pino J., et al. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One 2012, 7:e52533.
66. You T., Nicklas B.J. Chronic inflammation: role of adipose tissue and modulation by weight loss. Curr Diabetes Rev 2006, 2:29-37.
67. Messier S.P., Mihalko S.L., Legault C., Miller G.D., Nicklas B.J., DeVita P., et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA 2013, 310:1263-1273.
68. Beavers K.M., Beavers D.P., Newman J.J., Anderson A.M., Loeser R.F., Nicklas B.J., et al. Effects of total and regional fat loss on plasma CRP and IL-6 in overweight and obese, older adults with knee osteoarthritis. Osteoarthritis Cartilage 2015, 23:249-256.
69. Griffin T.M., Fermor B., Huebner J.L., Kraus V.B., Rodriguiz R.M., Wetsel W.C., et al. Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther 2010, 12:R130.
70. Griffin T.M., Huebner J.L., Kraus V.B., Yan Z., Guilak F. Induction of osteoarthritis and metabolic inflammation by a very high-fat diet in mice: effects of short-term exercise. Arthritis Rheum 2012, 64:443-453.
71. Olson S.A., Horne P., Furman B., Huebner J., Al-Rashid M., Kraus V.B., et al. The role of cytokines in posttraumatic arthritis. J Am Acad Orthop Surg 2014, 22:29-37.
72. Caron J.P., Fernandes J.C., Martel-Pelletier J., Tardif G., Mineau F., Geng C., et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 1996, 39:1535-1544.
73. Goodrich L.R., Phillips J.N., McIlwraith C.W., Foti S.B., Grieger J.C., Gray S.J., et al. Optimization of scAAVIL-1ra in vitro and in vivo to deliver high levels of therapeutic protein for treatment of osteoarthritis. Mol Ther Nucleic Acids 2013, 2:e70.
74. Frisbie D.D., Ghivizzani S.C., Robbins P.D., Evans C.H., McIlwraith C.W. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 2002, 9:12-20.
75. Glasson S.S. In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr Drug Targets 2007, 8:367-376.
76. Furman B.D., Strand J., Hembree W.C., Ward B.D., Guilak F., Olson S.A. Joint degeneration following closed intraarticular fracture in the mouse knee: a model of posttraumatic arthritis. J Orthop Res 2007, 25:578-592.
77. Furman B.D., Mangiapani D.S., Zeitler E., Bailey K.N., Horne P.H., Huebner J.L., et al. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis. Arthritis Res Ther 2014, 16:R134.
78. Zhang X., Mao Z., Yu C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res 2004, 22:742-750.
79. Chevalier X., Goupille P., Beaulieu A.D., Burch F.X., Bensen W.G., Conrozier T., et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009, 61:344-352.
80. Kraus V.B., Birmingham J., Stabler T.V., Feng S., Taylor D.C., Moorman C.T., et al. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage 2012, 20:271-278.
81. Honorati M.C., Meliconi R., Pulsatelli L., Cane S., Frizziero L., Facchini A. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford) 2001, 40:522-527.
82. Honorati M.C., Bovara M., Cattini L., Piacentini A., Facchini A. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage 2002, 10:799-807.
83. Chen L., Li D.Q., Zhong J., Wu X.L., Chen Q., Peng H., et al. IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis. Osteoarthritis Cartilage 2011, 19:711-718.
84. Cuellar V.G., Cuellar J.M., Golish S.R., Yeomans D.C., Scuderi G.J. Cytokine profiling in acute anterior cruciate ligament injury. Arthroscopy 2010, 26:1296-1301.
85. Cuellar J.M., Scuderi G.J., Cuellar V.G., Golish S.R., Yeomans D.C. Diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain. J Bone Joint Surg Am 2009, 91:2313-2320.
86. Miller R.E., Tran P.B., Das R., Ghoreishi-Haack N., Ren D., Miller R.J., et al. CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis. Proc Natl Acad Sci USA 2012, 109:20602-20607.
87. Takebe K., Rai M.F., Schmidt E.J., Sandell L.J. The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone. Osteoarthritis Cartilage 2015, 23:454-461.
88. Sherwood J., Bertrand J., Nalesso G., Poulet B., Pitsillides A., Brandolini L., et al. A homeostatic function of CXCR2 signalling in articular cartilage. Ann Rheum Dis 2014 Aug 18, pii: annrheumdis-2014-205546. [Epub ahead of print]. 10.1136/annrheumdis-2014-205546.
89. Ehrnthaller C., Ignatius A., Gebhard F., Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 2011, 17:317-329.
90. Cantatore F.P., Benazzo F., Ribatti D., Lapadula G., D'Amico S., Tursi A., et al. Early alteration of synovial membrane in osteoarthrosis. Clin Rheumatol 1988, 7:214-219.
91. Rosenthal A.K., Gohr C.M., Ninomiya J., Wakim B.T. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage. Arthritis Rheum 2011, 63:401-411.
92. Gobezie R., Kho A., Krastins B., Sarracino D.A., Thornhill T.S., Chase M., et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007, 9:R36.
93. Happonen K.E., Saxne T., Aspberg A., Morgelin M., Heinegard D., Blom A.M. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum 2010, 62:3574-3583.
94. Sjoberg A.P., Manderson G.A., Morgelin M., Day A.J., Heinegard D., Blom A.M. Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol 2009, 46:830-839.
95. Kalchishkova N., Furst C.M., Heinegard D., Blom A.M. NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J Biol Chem 2011, 286:27915-27926.
96. Wang Q., Rozelle A., Lepus C., Scanzello C., Song J., Larsen D., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011, 17:1674-1679.
97. Suresh R., Mosser D.M. Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv Physiol Educ 2013, 37:284-291.
98. Klune J.R., Billiar T.R., Tsung A. HMGB1 preconditioning: therapeutic application for a danger signal?. J Leukoc Biol 2008, 83:558-563.
99. Ehrchen J.M., Sunderkotter C., Foell D., Vogl T., Roth J. The endogenous toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009, 86:557-566.
100. Goh F.G., Piccinini A.M., Krausgruber T., Udalova I.A., Midwood K.S. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol 2010, 184:2655-2662.
101. Lees S., Golub S.B., Last K., Zeng W., Jackson D.C., Sutton P., et al. Bioactivity in an aggrecan 32-mer fragment is mediated via toll-like receptor 2. Arthritis Rheumatol 2015, 67:1240-1249.
102. Mahler E.A., Zweers M.C., van Lent P.L., Blom A.B., van den Hoogen F.H., van den Berg W.B., et al. Association between serum levels of the proinflammatory protein S100A8/A9 and clinical and structural characteristics of patients with established knee, hip, and hand osteoarthritis. Scand J Rheumatol 2015, 44:56-60.
103. van Lent P.L., Blom A.B., Schelbergen R.F., Sloetjes A., Lafeber F.P., Lems W.F., et al. Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis. Arthritis Rheum 2012, 64:1466-1476.
104. Schelbergen R.F., Blom A.B., van den Bosch M.H., Sloetjes A., Abdollahi-Roodsaz S., Schreurs B.W., et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on toll-like receptor 4. Arthritis Rheum 2012, 64:1477-1487.
105. Schelbergen R.F., de Munter W., van den Bosch M.H., Lafeber F.P., Sloetjes A., Vogl T., et al. Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis. Ann Rheum Dis 2014 Sep 1, pii: annrheumdis-2014-205480. [Epub ahead of print]. 10.1136/annrheumdis-2014-205480.
106. Schelbergen R.F., Geven E.J., van den Bosch M.H., Eriksson H., Leanderson T., Vogl T., et al. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis. Ann Rheum Dis 2015 May 12, pii: annrheumdis-2014-206517. [Epub ahead of print]. 10.1136/annrheumdis-2014-206517.
107. Midwood K.S., Hussenet T., Langlois B., Orend G. Advances in tenascin-C biology. Cell Mol Life Sci 2011, 68:3175-3199.
108. Chockalingam P.S., Glasson S.S., Lohmander L.S. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation. Osteoarthritis Cartilage 2013, 21:339-345.
109. Sofat N., Robertson S.D., Hermansson M., Jones J., Mitchell P., Wait R. Tenascin-C fragments are endogenous inducers of cartilage matrix degradation. Rheumatol Int 2012, 32:2809-2817.
110. Patel L., Sun W., Glasson S.S., Morris E.A., Flannery C.R., Chockalingam P.S. Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord 2011, 12:164.
111. Okamura N., Hasegawa M., Nakoshi Y., Iino T., Sudo A., Imanaka-Yoshida K., et al. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthritis Cartilage 2010, 18:839-848.
112. Nasi S., Ea H.K., Chobaz V., van Lent P., Liote F., So A., et al. Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis. Joint Bone Spine 2014, 81:320-324.